Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Sep;18(9):865-869.
doi: 10.1002/jhm.13068. Epub 2023 Feb 28.

Advancing pediatric medication safety using real-world data: Current problems and potential solutions

James W Antoon  1   2 , James A Feinstein  3 , Jennifer L Goldman  4 , Kathryn E Kyler  5 , Samir S Shah  6 ; Children's Hospital Association Pharmacoepidemiology and Drug Safety (Peds-Rx) Research Group
Collaborators, Affiliations

Advancing pediatric medication safety using real-world data: Current problems and potential solutions

James W Antoon et al. J Hosp Med. 2023 Sep.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Dr. Grijalva has received consulting fees from Pfizer, Sanofi, and Merck. Dr. Williams has received in-kind research support from Biomerieux.

Similar articles

See all similar articles

Cited by

References

    1. Lasser KE. Timing of new black box warnings and withdrawals for prescription medications. JAMA. 2002;287(17):2215–2220. - PubMed
    1. Sachs AN, Avant D, Lee CS, Rodriguez W, Murphy MD. Pediatric information in drug product labeling. JAMA. 2012;307(18): 1914–1915. - PubMed
    1. Hoon D, Taylor MT, Kapadia P, Gerhard T, Strom BL, Horton DB. Trends in off-label drug use in ambulatory settings: 2006-2015. Pediatrics. 2019;144(4):e20190896. doi: 10.1542/peds.2019-0896 - DOI - PMC - PubMed
    1. Shah SS, Hall M, Goodman DM, et al. Off-label drug use in hospitalized children. Arch Pediatr Adolesc Med. 2007;161(3):282–290. - PubMed
    1. Antoon JW, Hall M, Herndon A, et al. Prevalence of clinically significant drug-drug interactions across US children’s hospitals. Pediatrics. 2020;146(5):e20200858. doi: 10.1542/peds.2020-0858 - DOI - PMC - PubMed

Publication types

Substances